STOCK TITAN

iCAD to Report Fourth Quarter and Full Year 2021 Financial Results on Monday, February 28

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags
conferences earnings

Rhea-AI Summary

iCAD, a leader in medical technology focused on innovative cancer detection and therapy solutions, will release its financial results for Q4 and the full year ending December 31, 2021, on February 28, 2022, post-market closure. A conference call will follow at 4:30 PM ET, where they will discuss the results. Investors can join the call through domestic and international numbers provided or via a webcast link. For further information about iCAD, visit their official website.

Loading...
Loading translation...

Positive

  • Announcement of upcoming financial results may attract investor interest.
  • Scheduled earnings call provides transparency and engagement with stakeholders.

Negative

  • None.
Argus Session date unavailable
+7.27% session move Open Argus
Details

News Market Reaction – ICAD

The recorded move for ICAD in the trading session of this news was +7.27%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

NASHUA, N.H., Feb. 14, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will release financial results for the fourth quarter and year ended December 31, 2021, after the market close, and host a conference call at 4:30 PM Eastern Time on Monday, February 28.

Monday, February 28th at 4:30 PM ET

Domestic:877-407-0784
International:201-689-8560
Conference ID:13726987
Webcast:https://themediaframe.com/mediaframe/webcast.html?webcastid=ELUrpENc

About iCAD, Inc.
Headquartered in Nashua, NH, iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. For more information, visit www.icadmed.com.

Contact:
Media Inquiries:
Jessica Burns, iCAD
+1-201-423-4492
jburns@icadmed.com

Investor Inquiries:
iCAD Investor Relations
ir@icadmed.com


FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will iCAD release its Q4 2021 financial results?

iCAD will release its Q4 2021 financial results on February 28, 2022, after market close.

What time is the iCAD conference call scheduled for?

The iCAD conference call is scheduled for 4:30 PM ET on February 28, 2022.

How can I participate in the iCAD earnings call?

You can join the iCAD earnings call via domestic at 877-407-0784 or international at 201-689-8560.

What is the conference ID for the iCAD call?

The conference ID for the iCAD call is 13726987.

Where can I find more information about iCAD?

More information about iCAD can be found on their official website at www.icadmed.com.

Keep reading